Back
Cue Biopharma Quote, Financials, Valuation and Earnings
Sponsored
CUE
Sponsored
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Buy
54
CUE
Cue Biopharma
Last Price:
1.51
Seasonality Move:
5.19%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Cue Biopharma Price Quote
$1.51
+0.01 (+0.67%)
(Updated: November 15, 2024 at 3:09 AM ET)
Cue Biopharma Key Stats
Buy
54
Cue Biopharma (CUE)
is a Buy
Day range:
$1.45 - $1.60
52-week range:
$0.45 - $3.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.73
P/B ratio:
4.18%
Volume:
1.3M
Avg. volume:
1.1M
1-year change:
-39.02%
Market cap:
$90.3M
Revenue:
$5.5M
EPS:
$-0.98
How Much Does Cue Biopharma Make?
-
How Much Are Cue Biopharma's Sales Annually?
CUE Revenues are $5.5M -
How Much Profit Does Cue Biopharma's Make A Year?
CUE net income is -$50.7M
Is Cue Biopharma Growing As A Company?
-
What Is Cue Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.92% -
What Is Cue Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cue Biopharma Stock Price Performance
-
Did Cue Biopharma Stock Go Up Last Month?
Cue Biopharma share price went up by 23.97% last month -
Did CUE's Share Price Rise Over The Last Year?
CUE share price fell by -39.02% over the past 1 year
What Is Cue Biopharma 52-Week High & Low?
-
What Is Cue Biopharma’s 52-Week High Share Price?
Cue Biopharma has traded as high as $3.25 over the past 52 weeks -
What Is Cue Biopharma’s 52-Week Low Share Price?
Cue Biopharma has traded as low as $0.45 over the past 52 weeks
Cue Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cue Biopharma?
-
How Much Debt Does Cue Biopharma Have?
Total long term debt quarterly is $6.2M -
How Much Cash Does Cue Biopharma Have?
Cash and short term investments quarterly total is $30M -
What Is Cue Biopharma’s Book Value Per Share?
Book value per share is 0.44
Is Cue Biopharma Cash Flow Positive?
-
What Is CUE Cash Flow From Operations?
Cash flow from operations (TTM) is -$38.5M -
What Is Cue Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.7M -
What Is Cue Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $4.9M
Cue Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
CUE return on invested capital is -107.58% -
What Is Cue Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -78.3% -
What Is CUE Return On Equity?
ROE is a measure of profitability and is -132.34%
Cue Biopharma Earnings Date & Stock Price
-
What Is Cue Biopharma's Stock Price Today?
A single share of CUE can be purchased today for 1.50 -
What Is Cue Biopharma’s Stock Symbol?
Cue Biopharma trades on the nasdaq under the ticker symbol: CUE -
When Is Cue Biopharma’s Next Earnings Date?
The next quarterly earnings date for Cue Biopharma is scheduled on November 15, 2024 -
When Is CUE's next ex-dividend date?
Cue Biopharma's next ex-dividend date is May 26, 2020 -
How To Buy Cue Biopharma Stock?
You can buy Cue Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cue Biopharma Competitors
-
Who Are Cue Biopharma's Competitors?
Below is a list of companies who compete with Cue Biopharma or are related in some way:
Cue Biopharma Dividend Yield
-
What Is CUE Dividend Yield?
Cue Biopharma’s dividend yield currently is 0% -
What Is Cue Biopharma’s Payout Ratio?
Cue Biopharma’s payout ratio is 0% -
When Did Cue Biopharma Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Cue Biopharma’s Dividend Per Share?
Cue Biopharma pays a dividend of $0.00 per share
Cue Biopharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 28.57% |
Revenue: | 92.33% | 106.21% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 4.00 |
Upside from Last Price: | 166.67% |